Use of ceftazidime-avibactam for suspected or confirmed carbapenem-resistant organisms in children: a retrospective study

H Meng, Y Zhao, Q An, B Zhu, Z Cao… - Infection and Drug …, 2023 - Taylor & Francis
Background The incidence of carbapenem-resistant organism (CRO) infections is increasing
in children. However, pediatric-specific treatment strategies present unique challenges …

Insight into Antibiotic Synergy Combinations for Eliminating Colistin Heteroresistant Klebsiella pneumoniae

SG Rajakani, BB Xavier, A Sey, EB Mariem… - Genes, 2023 - mdpi.com
Colistin heteroresistance has been identified in several bacterial species, including
Escherichia coli and Klebsiella pneumoniae, and may underlie antibiotic therapy failures …

Antimicrobial Susceptibility from a One Health Perspective Regarding Porcine Escherichia coli from Bavaria, Germany

J Ade, JM Riehm, J Stadler, C Klose, Y Zablotski… - Antibiotics, 2023 - mdpi.com
Antimicrobial resistance is one of the most crucial One Health topics worldwide.
Consequently, various national and international surveillance programs collect data and …

Utilizing liposomal encapsulation approach to address nephrotoxic challenges of colistimethate sodium through a preclinical study

R Mektrirat, N Paengjun… - Frontiers in …, 2023 - frontiersin.org
The use of Colistin, a last-resort antimicrobial drug, carries the risk of acute kidney injury.
The objective of the study was to assess the effectiveness of colistin-encapsulated …

[HTML][HTML] Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii

S Ijaz, F Ansari, M Nawaz, H Ejaz, AA Anjum, A Saeed… - Medicina, 2024 - ncbi.nlm.nih.gov
Abstract Background and Objectives: Acinetobacter baumannii (A. baumannii), particularly
carbapenem-resistant A. baumannii (CRAB), represents a grave concern in healthcare …

[HTML][HTML] Clinical Reflections of Acinetobacter Infections in Children in a Quaternary-Care Hospital: A Five-Year Single-Center Experience

A Elvan-Tüz, D Tekin, Y Ekemen-Keleş… - Turkish Archives of …, 2024 - ncbi.nlm.nih.gov
Objective: This study aimed to determine the epidemiology of Acinetobacter species in the
last 5 years, the clinical diseases caused by the pathogen, the possible risk factors for …

An Ancient Drug for a Modern Era: Minocycline for the Treatment of Multi-Drug-Resistant Acinetobacter baumannii

V Punithavathi, AJ Ramalingam, S Chitralekha - Cureus, 2024 - search.proquest.com
Abstract Introduction: Infections caused by Acinetobacter baumannii are a major cause of
health concerns in the hospital setting. Moreover, the presence of extreme drug resistance in …

[PDF][PDF] An Ancient Drug for a Modern Era: Minocycline for the Treatment of Multi-Drug-Resistant Acinetobacter baumannii

P Velmurugan, AJ Ramalingam, C Saikumar - Cureus, 2024 - cureus.com
Abstract Introduction: Infections caused by Acinetobacter baumannii are a major cause of
health concerns in the hospital setting. Moreover, the presence of extreme drug resistance in …